The order of appearance of TET2 and JAK2 mutations impacts on the clinical phenotype, with “JAK2 first” patients typically presenting with PV, while “TET2 first” patients would rather present with ET/PMF [32]. Here, JAK2 is linked to essential thrombocythemia.